Biosimilar Firms Say Irish Price Deal Hinders Uptake, As Govt Plans New Policy Measures

 
• By Ian Schofield
  
Reducing costs
Ireland is banking on biosimilars to reduce drug costs
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics